Barclays Issues Pessimistic Forecast for RXO (NYSE:RXO) Stock Price

RXO (NYSE:RXO) had its price objective lowered by investment analysts at Barclays from $24.00 to $22.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price target would suggest a potential upside of 15.02% from the stock’s current price.

RXO has been the subject of several other research reports. The Goldman Sachs Group reduced their price objective on shares of RXO from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Thursday, February 6th. Wells Fargo & Company cut their price objective on RXO from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 27th. Deutsche Bank Aktiengesellschaft started coverage on RXO in a report on Friday, March 7th. They set a “hold” rating and a $19.00 price target on the stock. Stifel Nicolaus reduced their price objective on shares of RXO from $27.00 to $24.00 and set a “hold” rating for the company in a research note on Thursday, February 6th. Finally, Susquehanna lowered their target price on shares of RXO from $18.00 to $13.00 and set a “negative” rating on the stock in a research note on Wednesday, March 26th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, RXO presently has an average rating of “Hold” and a consensus target price of $24.80.

RXO Stock Up 1.1 %

NYSE:RXO traded up $0.21 on Wednesday, hitting $19.13. 51,358 shares of the company’s stock traded hands, compared to its average volume of 1,034,535. The company has a current ratio of 1.26, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. The company has a market cap of $3.12 billion, a PE ratio of -9.02, a price-to-earnings-growth ratio of 4.55 and a beta of 1.67. The firm has a 50-day moving average price of $21.05 and a 200-day moving average price of $25.09. RXO has a 1 year low of $17.50 and a 1 year high of $32.82.

RXO (NYSE:RXO) last issued its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. Equities analysts anticipate that RXO will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

Institutional investors have recently bought and sold shares of the business. Wilmington Savings Fund Society FSB bought a new position in shares of RXO in the third quarter valued at about $28,000. Blue Trust Inc. increased its position in RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after acquiring an additional 510 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of RXO by 228.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock worth $30,000 after purchasing an additional 868 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its holdings in shares of RXO by 68.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after purchasing an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its position in RXO by 407.0% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock valued at $43,000 after buying an additional 1,445 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.